Company Overview
DMCC Speciality Chemicals Limited submitted its FY2025-26 Annual Report and notice for its 105th AGM scheduled for September 11, 2026 via VC/OAVM to NSE and BSE. The company reported strong financial performance with consolidated revenue of ₹581.58 crore (up 34.84% YoY) and PAT of ₹27.33 crore (up 26.95%) despite raw material volatility and supply chain challenges.
Financial Performance Highlights
Revenue & Profitability: Revenue from operations reached ₹58,150.46 lakhs (₹581.58 crore) compared to ₹43,123.19 lakhs in FY25, driven by bulk chemicals segment growth with higher sulphuric acid realizations. Net profit stood at ₹2,733.18 lakhs (₹27.33 crore) versus ₹2,153.97 lakhs in the previous year. EBITDA increased 10.23% to ₹64.33 crore, though margins compressed to 11.04% from 13.49% due to cost pressures.
Balance Sheet & Cash Flow: Total assets increased to ₹44,550.62 lakhs with significant growth in inventories (₹9,189.32 lakhs vs ₹4,259.06 lakhs) and trade receivables (₹9,594.25 lakhs vs ₹7,417.45 lakhs). Net cash used in operating activities was ₹1,778.35 lakhs, while financing activities generated ₹2,237.62 lakhs. Debt-equity ratio stood at 0.44 compared to 0.32 previous year.
Operational & Segment Performance
Manufacturing Facilities: The company operates ISO-certified facilities in Roha, Maharashtra (88,356 sq.m., 350 MTPD sulphuric acid capacity) and Dahej, Gujarat (1,03,327 sq.m., boron and sulphur chemistry). Production faced challenges from Middle East conflict impacting sulphur supply and Turkish boron ore disruption in H1, though operations normalized in H2.
Segment Breakdown: Bulk chemicals drove growth with domestic demand and higher sulphur prices passed to customers. Speciality chemicals faced European market weakness offset by growth in Latin America, China, Japan, and Korea. The company maintains 44+ products and exports to 25+ countries.
Corporate Actions & Governance
Dividend & Capital Structure: Board recommended final dividend of ₹2.50 per share (25% on face value of ₹10) with record date of August 21, 2026. Equity share capital remained unchanged at ₹24.94 crore with 2,49,39,933 shares. Company seeks shareholder approval to enhance borrowing limits to ₹400 crore.
Board Composition: Dr. Janaki Ashwin Patwardhan resigned in October 2025, with Ms. Saloni Jhaveri appointed as Independent Director in January 2026. Key management includes Mr. Bimal L. Goculdas as MD & CEO and Mr. Kuldeep Kumar Tiwari as Executive Director (Operations).
Risk Factors & Contingencies
Market & Operational Risks: Sulphur price volatility, European demand weakness, dependence on imported raw materials, and geopolitical conflicts affecting supply chains. Contingent liabilities include excise/customs duty claims of ₹1,802.60 lakhs, GST appeals of ₹164.85 lakhs, and legal claims of ₹34.77 lakhs.
Regulatory Compliance: Financial statements prepared in accordance with Ind AS and Companies Act 2013, with unmodified audit opinion from Rahul Gautam Divan & Associates. CSR expenditure of ₹38.77 lakhs focused on education, healthcare, and environmental conservation.
Forward Outlook
Company maintains focus on operational stability and working capital management with no major capital expenditure obligations. Monitoring global sulphur price trends and Middle East situation while leveraging diversified portfolio across commodity, speciality and boron chemistry segments.